HOW THE SYMPOSIUM IS UNIQUE This Symposium features the presentation - - PDF document
INSTITUTE OF INTELLECTUAL PROPERTY II P RD RESEARCH AND DEVELOPMENT & SUGHRUE MION, PLLC, OF THE U S A SUGHRUE Presents THREE DAYS INTERNATIONAL SYMPOSIUM ON STRATEGIES FOR MANAGING PHARMA/BIOTECH/CHEMICAL PATENT PORTFOLIO With
Presents
ON
With Focus on:
SUGHRUE
AT
From:
With Support of :
ABOUT THE SYMPOSIUM HOW THE SYMPOSIUM IS UNIQUE
This Symposium features the presentation of all important patent issues covering Pharma Biotech and Chemicals products and processes. Composition of the panelists is a unique gathering of Patent Attorneys and Litigators from USA, Europe, China and India who have extensive years of experience in their professional fields and will put across to the delegates the real insight of Patent Laws and Practices and first-hand information through well coordinated and structured modules. This is a one time opportunity when Seven Patent/ Litigation Experts would be interacting with limited delegates and would answer to any question that the delegates may have. Symposium would also provide to its participants an exclusive opportunity to interact and discuss personal patent issues with speakers, even on one to one basis and if required in
Scientists, Patent Attorneys, and Legal Corporate team at Pharma, Biotech and Chemical Industry will get to know the real insight and nitty gritty followed at USPTO, Europe and China Patent Office. The knowledge gained from the workshop will go a long way in formulating the right patent strategy and managing Patent Portfolio. Research & Development Scientists, IP Managers, Patent Agents & Attorneys in the field of Practice, Patent Litigators and Managers in Generic Drugs Companies, Professionals in Legal Domain related to Pharma, Biotech and Chemicals.
WHO SHOULD ATTEND
In a business environment where competition in Pharma, Biotech and Chemical Industry is becoming increasingly aggressive, there is an urgent need to understand the competitive leverage that an efficient Intellectual Property Portfolio can provide. An understanding of International Patent Laws and Practices for regulating and protecting one's business, world over, becomes critical for the business growth and there is therefore an urgent need to understand important issues relating to strategies for generic pharmaceutical manufacturers, identification of invention, types of applicable claims, formulation of set of claims, drafting issues, claim drafting, review of recent case laws impacting claim drafting, amendments during prosecution, how to effectively understand and respond to communications from EPO and USPTO examiners for avoiding prosecution, litigation strategies, impact of major decisions on litigation strategies to extend product life when a drug comes off patent. At the same time Patent Laws & Practices differ substantially between Nations, in terms of their Grant, Scope, Protection and Enforcement mechanisms and therefore need to be well understood and this symposium is organized only in this
pharmaceutical manufacturers who seek to enter the U.S. market, obviousness issues relating to active pharmaceutical ingredients, evolving trends in declaratory judgment actions, unique aspects of Orange book listing strategies, litigating ANDA and strategic use
and Chemical Industry.
ABOUT THE FACULTY
expertise of 30 years in patent domain with focuses on Pharma, General Organic Chemistry and Biotechnology. Burchfiel was the first American patent lawyer admitted to practice in Japan under the reciprocal foreign law practice statute. His practice includes litigation before the federal courts, interferences and appeals. He also testifies as an expert witness
litigation and interference practice, Burchfiel counsels a variety of international and domestic clients regarding U.S. intellectual property law including providing clearance, enforceability, and validity opinions. Burchfiel has numerous publications and teaching and has spoken on various international symposium. He is also a visiting Scholar to Max-Planck among other universities/ Institutes.
an MS in Chemical Engineering from University of Akron and an MS in Computer Science from the University of Tennessee Space Institute. He received his JD from Georgetown University in 1997. Chid is a partner of International Law Firm of Sughrue Mion and is involved in all aspects of patent practice including litigation, prosecution and client counseling in a variety of technologies with focus on chemical and pharmaceutical. Chid has prepared and prosecuted over fifty applications for a leading research laboratory. Chid has conducted and presented in various workshops and seminars on patent practice at various locations in U.S, Korea, Japan, and India. He is currently chairing the AIPLA subcommittee on IP practice in India.
representing multinational companies in patent litigation, including trials and appeals of patent cases. His experience has encompassed technical areas that include pharmaceuticals, recombinantly produced hormones, protein synthesis and expression products, fibers, and medical devices. His interference practice has included topics in chemistry and biotechnology including hormone and gene therapeutics, as well as anticholesterics. Michael also counsels clients on intellectual property issues, including validity and infringement of intellectual property rights, licensing and contract matters and Hatch-Waxman
drafting pre-litigation opinions, pharmaceutical litigation strategies, and Patent Law Reform.
works out of the Washington office. He did his masters in Biological Sciences in 1995. Simmons practice focuses on worldwide procurement, defense and enforcement of patents in the biotechnology and chemical industries. Simmons works in all areas of patent law, including interferences, reexaminations, oppositions and prosecution. Simmons prepares opinions regarding patentability and infringement and conducts freedom-to-operate analysis. He did his Post-doctoral Fellow from National Institute of Health at New York University.
Invetigation for the last 35 years. Vinod started his practice in Intellectual Property in late nineties, with focus on Protection and Commercialization
Transfer of Technology, Licensing, and resolving IP disputes. Vinod has also been researching and educating on fighting thefts and frauds of Intellectual Properties and white-collar crimes to protect corporate
their investigation, Prosecution and Litigation Strategies such as Indian Oil Corporation, ITC, Bharti Tele venture among many others. Vinod is the Founder Director of the Institute of Intellectual Property Research & Development and is also the President of the Institute of Forensic Accounting and Investigative Audit. He is also the Senior Partner of Khurana & Khurana Advocates & IP
LLB among other specialized qualifications in Investigation.
Engineering from Dalian Marine University in 1982, and his International MBA from Hong Kong University of Science & Technology. Samson began his IP career in 1984 as a patent attorney with the CCPIT Patent and Trademark Law Office, eventually serving as deputy director of its German office. In 1990, he joined a U.S. IP firm in Silicon Valley as a patent agent. He returned to Beijing in 1995 and joined Kangxin Partners, P.C. in 1998 and was promoted to managing partner in 2001. He has successfully litigated numerous IP disputes involving patent infringement and unfair competition. Samson has been named as Asialaw Leading Lawyer by Asia Law & Practice four times since 2006 and the Leading Patent Attorney by the Beijing Intellectual Property Office in 2006, 2008 and 2009.
the largest firm of European Patent and Trade Mark Attorneys. Adrian received his primary education at Hyderabad Public School in Andhra Pradesh, where his father was British Council representative, Adrian did his first degree in Genetics at University College, London. His PhD was awarded by Imperial College, London for research in Molecular Biology based in the London laboratories of the Imperial Cancer Research Fund (now Cancer Research UK), where he investigated interferon-induced gene regulation. Adrian's patent work has covered many areas of life sciences, from small molecule chemistry in the pharmaceutical and herbicidal fields, through to recombinant DNA technology in the human, microbiological and plant sectors. Adrian has 20 years experience in patent prosecution, post-grant proceedings and litigation in the UK, Germany and Holland and in US interference proceedings. DATES : 2nd – 4th September 2009 VENUE: Le Royal Meridian, Sahar Road, Andheri East, Mumbai TYPE : Non Residential FEES : For Indian Delegates : Rs. 14339/- (Rs. 13000+1339 Service Tax) For Foreign Delegates : US$ 386/- (US$ 350/- + $ 36 Service Tax ) CONTACT PERSON: Tarun Khurana, +91-9810617992 (0120-2342010/3104849 Fax: 2342011) tarun@iiprd.com or Tarun@khuranaandkhurana.com
SCHEDULE
About IIPRD About SUGHRUE MION, PLLC, USA
Institute of Intellectual Property Research and Development is established to provide Education, Industrial Training, Consultancy and related services in the field of Intellectual Property Rights in an International scenario to the Indian business houses. In this direction, the Institute has held scores of National and International Seminars as one of its focused activities on its own and in collaboration with various Government and International agencies such as CSIR, TIFAC (Ministry of Science and Technology), European Patent Office among others. The Institute also conducts tailor-made IP educational programmes for better known Corporates at their premises specific to their needs & is also successfully running a 6-Months Distance-Learning course on 'Patent Portfolio Creation & Management' for Scientists & IP Practitioners. The Institute provides End-to-End support to all business houses to create, promote, protect and commercialize their Intellectual Properties to maximize the economic gains. In this direction, the Institute has helped various business establishments in formulating the right IP strategy. The Institute has established a Valuation Center which undertakes valuation of Intellectual Property. The Institute has undertaken multiple brand and technology valuations, which have gone through International deals. The Institute has an IPR Audit cell which undertakes IP Due-Diligence in order to Commercialise Intellectual Property and manage IPR-Risk. Further, the Institute provides route map and strategy for IP protection, transfer of technology, licensing, remittance, accounting of damages for infringements, verification of royalties and license fee to foreign countries. The Institute has In-House full service IP law firm by the name Khurana & Khurana, Advocates and IP Attorneys which provides end-to-end support for creating, protecting and managing Patent Portfolio of Corporates from across technology domains. If you wish to know more about the Institute please log on to www.iiprd.com. Sughrue Mion is one of the world's leading intellectual property law firms managing traditional and non-traditional intellectual property rights, for about five decades, with a wide range of clients around the world. Sughrue's more than 100 lawyers protect ideas- all ideas- and for nearly half a century have been helping their clients to develop, obtain, protect and leverage their intellectual property rights in technology areas ranging from a submicroscopic sequence of DNA to a vast constellation of satellites circling the globe. Sughrue's Pharmaceuticals, Biotechnology, Chemical attorneys are trained in technical disciplines that include molecular and cellular biology, biophysics, pharmaceuticals, chemistry, immunology, virology, genetics and agriculture biotechnology. Their experts are particularly well versed in drafting claims to ensure the broadest possible coverage and have a long established expertise in handling patent interference proceedings that may be critical to determining basic patent rights in new areas of biotechnological and pharmaceutical industries. Their litigators who specialize in chemistry have tried cases relating to pharmaceuticals, biotechnology, industrial chemical processes, specialty chemicals, and nanotechnology. Sughrue Mion handles a wide range of IP litigation matters for clients around the world, and when it comes to serving their clients, they go beyond traditional boundaries, advocating innovative theories and redefining the frontiers of law as they apply to creativity and
protection, management and exploitation strategy, effectively, as single point Corporate destination in US and abroad. If you wish to know more about Sughrue Mion please log on to www.sughrue.com.
ABOUT THE ORGANIZERS
0900-0930: Registration 0930-1130 : Developments in global biosimilars and prospects for legislation in major jurisdictions. 1130-1300 : Current trends in pharmaceutical, biotechnology & chemicals patent law and practice in the United States. 1300-1345: Lunch 1345-1515: How to draft a robust pharma, biotech & chemical patent, analyzing invention disclosure and capturing them in a sophisticated set of patent claims; comparing the different approaches of EPO and USPTO. 1530-1645: Obviousness issues related to active pharmaceutical ingredients;
court decisions on obviousness issues of active ingredients. 1645-1800: Using alternate USPTO procedures like Reexaminations and Interferences strategically in a preemptive manner to attain business goals. 0915-1115 : NDA and ANDA products: salts, polymorphs, cocrystals solvates and enantiomers, combination products; bracketing the IP space around NDA products, impurities, manufacturing processes, finished dosage forms and exportation to the US. 1130-1315 : Recent developments in the law every pharmaceutical company should know: old antibiotics, enantiomers, patent law reform, In Re Bilski, and selected court provisions. 1315-1400: Lunch 1400-1600: Preparing for the legal challenge; Orange Book patents, the opinion of counsel, the Paragraph 4 certification, offer of confidential access, jurisdiction and litigation strategy. 1615-1730: Single and multi-defendant litigation; managing e-discovery; the Markman hearing; working with a litigation budget; the effective use of experts; preparing for trial. 1730-1900: Resolving the ANDA litigation: settlement strategies; early market access agreements; authorized generics; FTC review; shared and unshared exclusivity, forfeiture, and citizens petitions. 1930-2130: Dinner Day-2 0915-1115 : Current trends in pharmacutical and biotechnology patent law and practice in the European Patent Office and how to effectively understand and respond to communications from EPO examiners for avoiding prosecution pitfalls. 1130- 1300: Patent Litigation; Patent trolls, patent portfolio structure, scientific risk analysis to initiate patent litigation. 1300-1345: Lunch 1345-1530: Chinese Patent Laws for Pharma and Biotech Industry and best practices for protection and enforcement, with focus on third reform of the Chinese patent Law. 1545-1730: To deliberate all issues, raised by the delegates and emerged during the conference, but were not adequately replied in the respective session due to paucity of time and deliberation on any new patent application aspect brought out by delegates.
PROGRAMME
Day-1 Day-3
For details log on to
OF
REGISTRATION FORM